Syapse enables healthcare providers to bring precision medicine to every cancer patient today.
launched a precision medicine program that will bring new treatment options to cancer patients.
Learn how
scaled precision medicine and clinical trials matching across their community and research clinics.
Learn how
uses real-world evidence from a national data-sharing network to improve cancer care in Michigan.
Learn how
“Syapse enables us to share robust, real-world evidence with other community health systems and research practices, linking us with our peers while keeping patient data secure. Together, we’re creating a new standard for evidence-driven precision cancer care.”
5/2/19 - Precision medicine company Syapse has launched a collaboration with its one-time Big Pharma benefactor Amgen, with the goal of mining real-world evidence for insights into cancer drug development. Together, Amgen and Syapse will develop observational research analytics aimed at assessing outcomes in areas of unmet need—starting by identifying existing patients within Syapseâs health network that may be eligible for clinical trials, and then bringing those studies to nearby sites.
Read
